| Display title | Atoltivimab/maftivimab/odesivimab |
| Default sort key | Atoltivimab Maftivimab Odesivimab |
| Page length (in bytes) | 20,034 |
| Namespace ID | 0 |
| Page ID | 65586668 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of page watchers | Fewer than 30 watchers |
| Number of redirects to this page | 4 |
| Counted as a content page | Yes |
| Wikidata item ID | Q104863841 |
| Local description | Fixed-dose combination of three monoclonal antibodies |
| Central description | fixed-dose combination of three monoclonal antibodies |
| Page views in the past 30 days | |
| Edit | Allow all users (no expiry set) |
| Move | Allow all users (no expiry set) |
| Page creator | Whywhenwhohow (talk | contribs) |
| Date of page creation | 02:20, 15 October 2020 |
| Latest editor | Maxim Masiutin (talk | contribs) |
| Date of latest edit | 21:09, 26 January 2024 |
| Total number of edits | 58 |
| Recent number of edits (within past 30 days) | 0 |
| Recent number of distinct authors | 0 |
| Hidden categories (19) | This page is a member of 19 hidden categories (help):
|
| Transcluded templates (142) | Pages transcluded onto the current version of this page (help):
|
| Wikidata entities used in this page | |
